The Royal College of Paediatrics and Child Health has accused NHS England of effectively conceding that it cannot meet acceptable waiting times for children, warning that the current operational guidance prioritises adult elective recovery in ways that leave younger patients without adequate attention.

The RCPCH's concerns centre on NHS England's 2024/25 and 2025/26 Operational Planning Guidance, which sets targets principally aimed at reducing the longest waits across the elective backlog. Because adults make up the overwhelming majority of patients waiting more than 52 weeks for treatment, the college argues that the metrics used to measure progress are structurally skewed away from children.

The college has described the situation as amounting to an admission of defeat. In its view, framing recovery around high-volume adult procedures such as hip and knee replacements produces a system in which paediatric services are treated as secondary, with trusts and integrated care boards directing capacity towards where national performance pressure is greatest.

This concern has been characterised by some within the college as the emergence of a two-tier system. Children requiring surgery, mental health intervention, or specialist assessment face waits that are growing proportionally faster than those for adults, yet the mechanisms designed to hold the NHS to account do not capture this adequately. The RCPCH argues that without ring-fenced targets specific to children's services, the gap will continue to widen regardless of overall headline improvements.

The clinical stakes are distinct from those in adult medicine. Delays in childhood carry developmental consequences that cannot be recovered later. A child waiting an additional year for orthopaedic surgery, autism assessment, or mental health support is not simply experiencing an inconvenience deferred. Clinicians describe a window during which timely intervention can alter a child's trajectory, and outside of which the same treatment yields considerably less benefit. The college contends that NHS England's current approach does not reflect this clinical reality in its planning assumptions.

Published NHS data indicates that paediatric waiting lists have grown sharply since the pandemic, with the number of children waiting more than 18 weeks for treatment in several specialties remaining high. In some areas, particularly child and adolescent mental health services, waits have extended well beyond those seen before 2020 and show limited signs of material reduction.

NHS England has maintained that its operational guidance is designed to stabilise the entire elective system and drive progress against the 18-week referral-to-treatment standard. The health service set a target of 65 per cent of patients being treated within 18 weeks by March 2026, a goal that requires concentrated effort across a system still carrying the volume consequences of pandemic-era disruption. Spokespeople have pointed to the overall scale of the backlog as justification for a strategy that focuses resources where waits are numerically longest.

The difficulty of the position NHS England occupies is not straightforward. Urgent care pressures, workforce constraints, and the breadth of the elective backlog mean that any prioritisation involves trade-offs. Paediatric services require specialist staff, facilities, and pathways that cannot simply be expanded by redirecting capacity from adult elective work. The resource arguments are real, even where the RCPCH disputes the conclusions drawn from them.

The college is pressing for dedicated performance standards for children that sit alongside, rather than within, the existing elective recovery framework. It wants NHS England to publish waiting time data broken down by age group in a manner that makes paediatric performance visible and measurable. Without that transparency, the college argues, there is no accountability mechanism capable of driving change in the right direction.

The longer-term warning is financial as much as clinical. Children who miss treatment during critical developmental periods tend to require more intensive intervention later. The RCPCH has argued that the NHS will face higher costs, greater demand on specialist services, and a larger burden of preventable illness if the current approach is left unchanged through the remainder of the recovery period.